Brielle Urciuoli | Authors


Researchers Exploring Ways to Combat Drug Resistance in Melanoma

March 14, 2017

Helmut Schaider, MD, discusses why drug resistance in melanoma may be due to epigenetic changes and not mutation-induced changes, as well as the role of immunotherapy/targeted therapy combinations in combating resistance.

Rucaparib Promising Agent for Patients With Relapsed Ovarian Cancer

March 14, 2017

Patients with relapsed, platinum-sensitive, high-grade, ovarian cancer saw activity with the PARP inhibitor rucaparib, according to findings from the ARIEL2 study presented at the Society for Gynecologic Oncology 48th Annual Meeting in National Harbor, Maryland.